NEW YORK, June 19, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or "the Company") today announced the closing of its previously announced public offering of 76 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results